Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bortezomib/dexamethasone
(Synonym: D00975)
[2] Bortezomib,
Dexamethasone
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150
[2] NR3C1,
PSMB5 💬
[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283
2Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
(Synonym: D00975)
[2] Bortezomib,
Dexamethasone
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150
[2] NR3C1,
PSMB5 💬
[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
3Bupivacaine/epinephrine/dexamethasone
(Synonym: D00975)
[3] Bupivacaine,
Dexamethasone,
Epinephrine
[14] D00095 ,
D00292 ,
D00975 ,
D00996 ,
D01450 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02149 ,
D02174 ,
D02591 ,
D02592 ,
D07552
[15] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 96
4Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
(Synonym: D00975)
[3] Azathioprine,
Dexamethasone,
Rituximab
[12] D00238 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 ,
D03033
[2] MS4A1,
NR3C1 💬
[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 35
5Control intervention (no dexamethasone)
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
6Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
(Synonym: D00975)
[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone
[21] D00088 ,
D00292 ,
D00472 ,
D00473 ,
D00973 ,
D00975 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D01998 ,
D02156 ,
D02174 ,
D02591 ,
D02592 ,
D03301 ,
D07749
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
7Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
(Synonym: D00975)
[3] Bortezomib,
Cyclophosphamide,
Dexamethasone
[12] D00287 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760
[2] NR3C1,
PSMB5 💬
[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
8Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
(Synonym: D00975)
[3] Bortezomib,
Cyclophosphamide,
Dexamethasone
[12] D00287 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760
[2] NR3C1,
PSMB5 💬
[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
9Cyclophosphamide, Bortezomib, dexamethasone
(Synonym: D00975)
[3] Bortezomib,
Cyclophosphamide,
Dexamethasone
[12] D00287 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760
[2] NR3C1,
PSMB5 💬
[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
10Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
(Synonym: D00975)
[4] Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone
[13] D00287 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D03150 ,
D07760 ,
D10777
[3] CD38,
NR3C1,
PSMB5 💬
[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28
11Dexamethasone
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
12Dexamethasone (1 cycle)
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 63
13Dexamethasone (4 cycles)
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 63
14Dexamethasone (50mg 1dd6, 3 consecutive days/month)
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 35
15Dexamethasone (or equivalent)
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 257
16Dexamethasone 0,1 mg Tablets
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
17Dexamethasone 0,5mg
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
18Dexamethasone 0.5mg Tablet
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
19Dexamethasone 0.5mg/5ml solution
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 35, 162
20Dexamethasone 0.5mg/5ml solution in Mucolox™
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 35, 162
21Dexamethasone 1,5 mg Tablets
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
22Dexamethasone 21-dihydrogen phosphate
(Synonym: D00975)
[3] Dexamethasone,
Hydrogen,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65
23Dexamethasone 21-phosphate
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
24Dexamethasone 2mg Tablets
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
25Dexamethasone 4 mg JENAPHARM
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 28
26Dexamethasone Abcur
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 63
27Dexamethasone and Rituximab
(Synonym: D00975)
[2] Dexamethasone,
Rituximab
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994
[2] MS4A1,
NR3C1 💬
[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63
28Dexamethasone given orally
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
29Dexamethasone injection
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 90
30Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 235
31Dexamethasone Parotid Irrigation
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 53
32DEXAMETHASONE SODIUM PHOSPHATE
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 65, 70, 96
33Dexamethasone sodium phosphate (soluzione 25mg/ml)
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65
34Dexamethasone sodium phosphate 250 mg/ 10 ml
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 96
35Dexamethasone sodium phosphate 250 mg/10 ml solution
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 299
36DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65
37DEXAMETHASONE SODIUM SULFATE
(Synonym: D00975)
[3] Dexamethasone,
Sodium sulfate,
Sulfate ion
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D05877
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 28
38Dexamethasone soduim phosphate
(Synonym: D00975)
[2] Dexamethasone,
Phosphate ion
[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 13
39Dexamethasone, 40 mg
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 28
40Dexamethasone, procarbazine
(Synonym: D00975)
[2] Dexamethasone,
Procarbazine
[11] D00292 ,
D00478 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D08423
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 65
41Diagnostic Test: Dexamethasone test
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75
42Epidural steroid (dexamethasone) injection
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 70
43High dose Dexamethasone pulses
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 63
44Intraarticular dexamethasone
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
45Intravenous Dexamethasone 1 mg
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
46Lenalidomide and dexamethasone
(Synonym: D00975)
[2] Dexamethasone,
Lenalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
47Lenalidomide+Dexamethasone
(Synonym: D00975)
[2] Dexamethasone,
Lenalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
48Lenalidomide, Dexamethasone
(Synonym: D00975)
[2] Dexamethasone,
Lenalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
49Lenalidomide, Dexamethasone and Cyclophosphamide
(Synonym: D00975)
[3] Cyclophosphamide,
Dexamethasone,
Lenalidomide
[12] D00287 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687 ,
D07760
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28
50Melphalan, thalidomide and dexamethasone
(Synonym: D00975)
[3] Dexamethasone,
Melphalan,
Thalidomide
[11] D00292 ,
D00369 ,
D00754 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28
51MMF and Dexamethasone
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 222
52Peri-neural Dexamethasone 1 mg
(Synonym: D00975)
[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
53Pomalidomide and Dexamethasone
(Synonym: D00975)
[2] Dexamethasone,
Pomalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D08976
[3] IL6,
NR3C1,
TNF 💬
[81] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28